Inmune Bio's total assets for Q3 2024 were $52.78M, an increase of 0.63% from the previous quarter. INMB total liabilities were $14.11M for the fiscal quarter, a -12.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.